Indian American business leader aims to build a world-class delivery and performance platform at leading medical technology ...

BD, a leading global medical technology company, and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector, announced a definitive agreement for BD to ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

On February 5, 2025, Becton, Dickinson and Company (BD) announced plans to separate its Biosciences and Diagnostic Solutions business into an independent entity. The Biosciences and Diagnostic ...

Q2 fiscal 2026 Management view "We delivered a solid second quarter with revenue, adjusted margins and adjusted EPS all ahead of our expectations" (President, CEO & Chairman Thomas Polen), adding, ...

A growing number of financial advisors have been leaving their broker-dealer (BD) firms to start or join a registered investment advisor (RIA), an annual industry analysis has found. The study noted ...

Chris DelOrefice, executive vice president and CFO of Becton, Dickinson plans to leave the company on Dec. 5 for “a new professional opportunity.” BD is currently searching for a new CFO to take over ...

FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)--BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...